CN103396310B - Method for separating and purifying eicosapentaenoic acid ester and docosahexenoic acid ester from micro-algal oil or fish oil - Google Patents
Method for separating and purifying eicosapentaenoic acid ester and docosahexenoic acid ester from micro-algal oil or fish oil Download PDFInfo
- Publication number
- CN103396310B CN103396310B CN201310319421.6A CN201310319421A CN103396310B CN 103396310 B CN103396310 B CN 103396310B CN 201310319421 A CN201310319421 A CN 201310319421A CN 103396310 B CN103396310 B CN 103396310B
- Authority
- CN
- China
- Prior art keywords
- ester
- extraction
- liquid
- acid ester
- micro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 eicosapentaenoic acid ester Chemical class 0.000 title claims abstract description 91
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 title claims abstract description 73
- 238000000034 method Methods 0.000 title claims abstract description 46
- 235000019198 oils Nutrition 0.000 title claims abstract description 32
- 235000021323 fish oil Nutrition 0.000 title claims abstract description 24
- 235000020673 eicosapentaenoic acid Nutrition 0.000 title abstract description 52
- 229960005135 eicosapentaenoic acid Drugs 0.000 title abstract description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 title abstract 3
- 150000002148 esters Chemical class 0.000 claims abstract description 55
- 239000002608 ionic liquid Substances 0.000 claims abstract description 21
- 238000000926 separation method Methods 0.000 claims abstract description 17
- 239000012046 mixed solvent Substances 0.000 claims abstract description 12
- 239000012454 non-polar solvent Substances 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 239000002798 polar solvent Substances 0.000 claims abstract description 9
- 238000000605 extraction Methods 0.000 claims description 115
- 239000007788 liquid Substances 0.000 claims description 65
- 239000000203 mixture Substances 0.000 claims description 50
- 239000003795 chemical substances by application Substances 0.000 claims description 36
- 238000005406 washing Methods 0.000 claims description 35
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 26
- 229930195729 fatty acid Natural products 0.000 claims description 26
- 239000000194 fatty acid Substances 0.000 claims description 26
- 238000005194 fractionation Methods 0.000 claims description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 20
- 150000004702 methyl esters Chemical group 0.000 claims description 18
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical class CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 14
- 150000002500 ions Chemical class 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 5
- 150000001450 anions Chemical class 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 241000195493 Cryptophyta Species 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 4
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- MQASTYLYFVNGGD-UHFFFAOYSA-N B(O)(O)O.N#CC#N Chemical class B(O)(O)O.N#CC#N MQASTYLYFVNGGD-UHFFFAOYSA-N 0.000 claims description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 3
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 125000004494 ethyl ester group Chemical group 0.000 claims description 3
- AVRGPVXXZLTCBB-UHFFFAOYSA-N methane oxalonitrile Chemical compound N#CC#N.C AVRGPVXXZLTCBB-UHFFFAOYSA-N 0.000 claims description 3
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- ZJKABZNFELLAQQ-UHFFFAOYSA-N octane Chemical compound CCCCCCCC.CCCCCCCC ZJKABZNFELLAQQ-UHFFFAOYSA-N 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract description 4
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract description 3
- 239000003495 polar organic solvent Substances 0.000 abstract description 2
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 8
- 238000011068 loading method Methods 0.000 description 7
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 5
- 239000004202 carbamide Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000004817 gas chromatography Methods 0.000 description 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 4
- 101710134784 Agnoprotein Proteins 0.000 description 3
- PIFPCDRPHCQLSJ-UHFFFAOYSA-N Clupanodonic acid Natural products CCC=CCCC=CCC=CCCC=CCCC=CCCC(O)=O PIFPCDRPHCQLSJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000021290 n-3 DPA Nutrition 0.000 description 3
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000000194 supercritical-fluid extraction Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- XUQBFMJGHHYFCP-UHFFFAOYSA-N 2-(2-chloroethyl)-3,4,5,6-tetrahydro-1h-2-benzazocine;hydrochloride Chemical compound Cl.C1N(CCCl)CCCCC2=CC=CC=C21 XUQBFMJGHHYFCP-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 241000270666 Testudines Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- VCDLWFYODNTQOT-UHFFFAOYSA-N docosahexaenoic acid methyl ester Natural products CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC VCDLWFYODNTQOT-UHFFFAOYSA-N 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000000199 molecular distillation Methods 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- SLZPKTPKHUFPLD-UHFFFAOYSA-N 1-butyl-3-methyl-1,2-dihydroimidazol-1-ium;thiocyanate Chemical compound [S-]C#N.CCCC[NH+]1CN(C)C=C1 SLZPKTPKHUFPLD-UHFFFAOYSA-N 0.000 description 1
- KAIPKTYOBMEXRR-UHFFFAOYSA-N 1-butyl-3-methyl-2h-imidazole Chemical compound CCCCN1CN(C)C=C1 KAIPKTYOBMEXRR-UHFFFAOYSA-N 0.000 description 1
- LRRVBLSOIBDURC-UHFFFAOYSA-M 1-butylpyridin-1-ium;acetate Chemical compound CC([O-])=O.CCCC[N+]1=CC=CC=C1 LRRVBLSOIBDURC-UHFFFAOYSA-M 0.000 description 1
- IBZJNLWLRUHZIX-UHFFFAOYSA-N 1-ethyl-3-methyl-2h-imidazole Chemical compound CCN1CN(C)C=C1 IBZJNLWLRUHZIX-UHFFFAOYSA-N 0.000 description 1
- PIFPCDRPHCQLSJ-WYIJOVFWSA-N 4,8,12,15,19-Docosapentaenoic acid Chemical compound CC\C=C\CC\C=C\C\C=C\CC\C=C\CC\C=C\CCC(O)=O PIFPCDRPHCQLSJ-WYIJOVFWSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000199914 Dinophyceae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000003859 hyphenated technique Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 238000003822 preparative gas chromatography Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 238000004808 supercritical fluid chromatography Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
Abstract
The invention discloses a method for separating and purifying eicosapentaenoic acid ester and docosahexaenoic acid ester from micro-algal oil or fish oil. The method comprises the steps of: by taking a non-polar solvent as a raw solvent and a polar solvent, ionic liquid and ionic liquid-polar organic solvent binary mixed solvent as an extractant, separating and preparing high-purity eicosapentaenoic acid ester (EPA ester) and docosahexaenoic acid ester (DHA ester) from the micro-algal oil or fish oil containing aliphatic esters with different saturability. The method is simple to operate, high in separation efficiency, less in solvent consumption, high in product purity, high in yield, easy to industrially produce and the like.
Description
Technical field
The present invention relates to technical field of chemical separation, the method for specific design a kind of separation and purification eicosa-pentaenoic acid esters (EPA ester) and docosahexenoic acid ester (DHA ester) from micro-algae oil or fish oil.
Background technology
Timnodonic acid (EPA) and docosahexenoic acid (DHA) all belong to ω-3 race unsaturated fatty acids, are the lipid acid of needed by human.Micro-algae, belongs to containing the chlorophyllous marine microorganism that swims, " can eat " carbonic acid gas, produce grease by photosynthesis, containing abundant polyenoic acid lipid acid in its grease.In addition, bathypelagic fish contains the high unsaturated fatty acid of a large amount of high values, especially EPA and DHA.Micro-algae oil and fish oil are all main raw materials of the high-purity EPA ester of preparation and DHA ester.
EPA and DHA plays vital effect to the healthy of people, has multiple physiological function.The laudatory title that EPA has " blood vessel street cleaner ", it mainly acts on cardiovascular systems, has reducing blood-fat, blood pressure and cholesterol, and prevention of arterial hardens; Reduce thrombosis, prevention cardiovascular and cerebrovascular diseases; Prevention senile dementia; Anticancer, Tumor suppression; The effect such as prevent and treat diabetes, anti-inflammatory, delay senility.And DHA, be commonly called as " DHA (docosahexaenoic acid) ", hemato encephalic barrier can be passed through; enter brain; act on neural system, DHA is except all physiological functions with EPA, and DHA also has to protect retina, improves eyesight, promotes infant intelligent development, improves the effects such as memory.
In the micro-algae oil of methyl esters type after just extracting or ethyl ester type fish oil, EPA ester and DHA ester and other low-unsaturation-degrees and polyunsaturated fatty acid ester exist jointly, go for highly purified EPA ester and DHA ester, need to take suitable separation method, EPA ester and DHA ester are separated with other fatty acid esters.Because the structure of fatty acid ester is all comparatively similar with physico-chemical property, be separated from the micro-algae oil of ester type or fish oil with DHA ester by EPA ester, the difficulty obtaining high purity EPA ester and DHA ester is larger.The separation method of patent and bibliographical information mainly contains the crystallizing process under low temperature, molecular distillation method, urea adduct method, supercritical fluid extraction, AgNO
3complexometry, absorption method etc.
CN200910159368.1 discloses a kind of method extracting DHA from dino flagellate fermentation liquor, and fermentation liquor process obtains thick algae oil, and then thick algae oil is through 5 grades of continuous molecular distillations, and obtain the product that DHA content is 40%-50%, product purity is relatively low.
Patent CN1263145 discloses and adopts urea adduct method enrichment from crude fish oil to produce to be rich in the refined fish oil of polyenoid acid esters, and this technique can obtain the product that EPA ester and DHA ester total content are more than or equal to 75%.CN200810052840.7 and CN201210247842.8 discloses a kind of urea adduct method that adopts and be separated the method preparing clupanodonic acid and docosahexenoic acid mixed fatty acid from micro-algae oil, the cost of this technique is lower, be applicable to industrial applications, but this method (urea adduct method) consumes a large amount of organic solvents and urea, and product purity is relatively low.
Patent CN1478875A discloses a kind of employing AgNO
3aqua-solution method, to the technology of the separation of fish oil esterified prod, can be prepared EPA ester+DHA ester total content and be greater than 95% and the DHA ester content product that is greater than 95%.But heavy metal Ag can bring in product by this method, and AgNO
3expensive, be not suitable for suitability for industrialized production.
CN200810052839.4 discloses a kind of silver ions column chromatography that adopts and is separated the high-purity clupanodonic acid methyl esters of preparation and Methyl docosahexaenoate, although this method can obtain clupanodonic acid methyl esters and the Methyl docosahexaenoate of higher degree, but employ expensive silver, and treatment capacity is less, solvent-oil ratio is comparatively large, easily causes the loss of silver and the heavy metal contamination of product.
CN1634852A discloses a kind of method utilizing supercritical fluid chromatography technology separation to prepare high-purity EPA ester and DHA ester, and obtain EPA ester and DHA ester product that purity is greater than 90%, but its treatment capacity is quite little, equipment cost is higher.JP09263787 adopts the method for liquid-liquid extraction to be separated to prepare highly unsaturated fatty acids ester, and this method uses acetonitrile-water mixture to be extraction agent, but due to the high hydrophobicity of fatty acid ester, causes its loading capacity and yield all very low.
In order to obtain the higher EPA ester of purity and DHA ester, the conbined usage of 2 kinds or separation method of more than two kinds is also the method often used.CN102285880A discloses a kind of half preparation/preparative high performance liquid chromatography-mass spectrometric hyphenated technique and is separated preparation EPA ester and DHA ester, obtains EPA ester and DHA ester that first reading is greater than 99%.Although the separation selectivity that this method can obtain high purity EPA ester and DHA ester is better, treatment capacity is less, and cost is higher, and the solvent that the toxicity such as more use tetrahydrofuran (THF) or acetonitrile is larger.CN1986515A discloses the omega-3 unsaturated fatty acid in the direct enrichment Turtle Oil of a kind of technology adopting supercritical extraction to combine with the crystallizing process under low temperature, and in the Turtle Oil extract obtained, the total content of EPA and DHA is 25%-30%.JP09157684A reports and adopts supercritical extraction to be separated with the coupling technique of chromatography and to prepare highly purified high unsaturated fatty acid ester, although this coupling technique can obtain highly purified single product, but chromatographic treatment capacity is less, and consume a large amount of organic solvents.
Summary of the invention
The invention provides a kind of method of separation and purification eicosa-pentaenoic acid esters and docosahexenoic acid ester from micro-algae oil or fish oil.Preparation technology is simple, product yield and purity high, cost is low.
A method for separation and purification eicosa-pentaenoic acid esters and docosahexenoic acid ester from micro-algae oil or fish oil, comprises the following steps:
(1) micro-for ester type algae oil or ester type fish oil are dissolved in non-polar solvent preparation raw material liquid, with the binary mixed solvent of polar solvent or ionic liquid or ionic liquid-polar solvent composition for extraction agent, with the solvent identical with material solution for washing composition, carry out fractionation extraction, collect extraction liquid;
(2) described extraction liquid is stripped through described non-polar solvent, strip liquor is obtained after vacuum concentration, washing also drying the mixture of eicosa-pentaenoic acid esters and docosahexenoic acid ester.Described fractionation extraction is divided into extraction section and washing section, extraction agent enters fractionation extraction system from the extraction section first step, stock liquid enters fractionation extraction system from extraction section last step, washing composition enters fractionation extraction system from the washing section first step, mix with stock liquid at the last step of extraction section, enter extraction section together, extraction phase carries out multi-stage countercurrent mutually with washing and contacts.Flow out the extraction liquid being rich in eicosa-pentaenoic acid esters (EPA ester) and docosahexenoic acid ester (DHA ester) from the washing section first step, collect extraction liquid; Flow out the raffinate being rich in low unsaturated and polyunsaturated fatty acid ester from the extraction section first step, collect raffinate.
For fractionation extraction, its core of innovation and technological difficulties are that the design of extraction agent is with preferred.Extraction agent must can identify the small structural differences of EPA ester and DHA ester and other fatty acid esters, realizes optionally extracting and separating, and extraction agent also needs to have higher loading capacity to fatty acid ester simultaneously.But because fatty acid ester is a quasi-grease compound, structure lacks polar group, the solubleness thus in polarity extracting agent is lower, thus cause the loading capacity of extraction agent lower, be unfavorable for large-scale application.
The room temperature that ionic liquid is made up of zwitterion or close to being liquid material under room temperature is the novel separating medium of a class green.The zwitterion structure of ionic liquid is adjustable, can for the fine difference on the structures and characteristics of target compound and impurity, by designing the zwitterion structure of ionic liquid to regulate interaction mode and the intensity of ionic liquid and solute, reach specific separating effect.The ion liquid abstraction agent of the present invention's design has higher loading capacity and selectivity is high.
Major part viscosity of il is lower, can be directly used in extraction.The viscosity of some ionic liquid is comparatively large, is difficult to be directly used in extraction.Research finds in ionic liquid, add dimethyl sulfoxide (DMSO), dimethyl formamide, acetonitrile, methyl alcohol polar solvent, and composition ionic liquid-polar solvent composite extractant, has higher separation selectivity and loading capacity equally, and viscosity is lower simultaneously.
Described ionic liquid is by positively charged ion M
+and anion N
-two portions are formed:
Described positively charged ion M
+for the one that there is single or multiple substituent choline cation, there is single or multiple substituting group glyoxaline cation, there is single or multiple substituent pyridine type positively charged ion, there is single or multiple substituting group quaternary ammonium cation and have in single or multiple substituting group benzimidazolium; Described substituting group to be carbonatoms be 1 ~ 8 alkyl, when substituting group has multiple, each substituting group can identical also can not be identical.
Anion N
-for the one that carbonatoms is in the fatty acid radical of 1-18, thiocyanate ion, dicyanamide root, three cyanogen methane roots, four cyanogen borates, halide-ions, tetrafluoroborate and phenol.
Described anion N
-for fatty acid radical, thiocyanate ion, dicyanamide root, three cyanogen methane roots, four cyanogen borates, halide-ions, one in tetrafluoroborate and phenol that carbonatoms is 1 ~ 18.
Preferred carbonatoms is the negatively charged ion of fatty acid radical as ionic liquid of 1-18, and this type of ionic liquid, owing to having long non-polar carbon chains, has very high loading capacity to EPA ester and DHA ester.
Described non-polar solvent is the one in normal hexane, normal heptane, octane and sherwood oil.
Described intensive polar solvent to be carbon atom number be 1 ~ 4 monohydroxy-alcohol, carbon atom number be 1 ~ 4 polyvalent alcohol, furfural, acetonitrile, dimethyl formamide (DMF), dimethyl sulfoxide (DMSO) (DMSO), N-Methyl pyrrolidone (NMP), one in tetramethylene sulfone.
The massfraction of described binary mixed solvent intermediate ion liquid is 5 ~ 70%.When using binary mixed solvent for extraction agent and forming two-phase extraction system with non-polar organic solvent, the separation selectivity of extraction system to EPA ester and DHA ester can be significantly improved, especially, when the viscosity of il used is larger, the resistance to mass transfer of effective reduction two-phase system, improve extraction efficiency, be conducive to large-scale commercial production.
The micro-algae oil of described ester type is methyl esters type, and in the micro-algae oil of ester type, the total mass mark of eicosa-pentaenoic acid esters and docosahexenoic acid ester is 5% ~ 50%; Described ester type fish oil is ethyl ester type, and in ester type fish oil, the total mass mark of eicosa-pentaenoic acid esters and docosahexenoic acid ester is 5% ~ 80%.
In described stock liquid, the total concn of fatty acid ester is preferably 10 ~ 200g/L, more preferably 20 ~ 150g/L.
If the total concn of fatty acid ester is too high in stock liquid, the viscosity of stock liquid is too large, is unfavorable for extracting mass transfer process, and can reduces separation selectivity; If the concentration of fatty acid ester is too low in stock liquid, then there is the shortcomings such as feed throughput is little, solvent consumption large, process economy reduction.
The temperature of described fractionation extraction is 20 ~ 40 DEG C.If temperature is too low, two-phase rate of mass transfer reduces, and reaches extraction equilibrium required time longer, is unfavorable for production operation; If temperature is too high, solvent evaporates is serious, and esters of polyunsaturated fatty acids is heat-sensitive substance, is at high temperature very easily oxidized, and reduces partition ratio and the selectivity of extraction.
Described stock liquid, extraction agent, washing composition stream ratio are 0.2 ~ 0.8:0.3 ~ 0.8:0.8 ~ 3.
The vacuum concentration of strip liquor, washing, drying step are routine operation.
The extraction plant that the extraction plant used in described fractionation extraction process is packing tower, sieve-tray tower, rotating disc contactor, mixer-settler, centrifugal extractor etc. are common.
In flash liberation process, stock liquid solvent, washing composition and back extraction time extraction agent be same solvent.
The present invention adopts gas-chromatography (GC) to analyze, concrete GC analysis condition is: CP7489(100m x2.5mm ID, thickness 0.2 μm), fid detector, sampler temperature 250 DEG C, detector temperature 280 DEG C, column temperature adopts temperature programming: initial temperature is 80 DEG C, keep 4min, rise to 220 DEG C with the temperature rise rate of 10 DEG C/min, keep 30min.Carrier gas is N
2, flow velocity 1ml/min, splitting ratio is 50.
In the present invention, the method for calculation of yield and purity are as follows:
In yield=product EPA ester and DHA ester quality/raw material in quality × 100% of EPA ester and DHA ester;
Total mass × 100% of the EPA ester in absolute purity=product and the quality/product of DHA ester;
Compared with prior art, tool of the present invention has the following advantages:
1. the present invention adopts the binary mixed solvent-nonpolar solvent extraction system of polar solvent-non-polar solvent, ionic liquid-non-polar solvent, ionic liquid and polar solvent, to the various fatty acid esters of structural similitude, there is higher selective separation ability, and loading capacity is large.
2. the present invention adopts fractionation extraction technology, have easy and simple to handle, flow process is simple, yield is high, product purity is high, also has the advantage that treatment capacity is large, be easy to industrial applications in addition.
3. the inventive method adopts the condition optimized, and the purity of EPA ester+DHA ester can reach 90-99%, and the rate of recovery of EPA ester+DHA ester can reach more than 90%.
4. the ion liquid abstraction agent that the inventive method uses has high, the nonflammable feature such as non-explosive of stability, improves the security of separating and extracting process; Ionic liquid is a kind of eco-friendly solvent simultaneously, as extraction agent, can reduce the pollution to environment, have broad application prospects; The recovery of ionic liquid is easier to, and is convenient to the recycling of extraction agent.
Embodiment
In below implementing, vapor-phase chromatography (GC) is adopted to carry out quantitative analysis to EPA ester and DHA ester.Raw material used all adopts commercial goods.
The process of fractionation extraction is:
Extraction agent enters fractionation extraction system from the extraction section first step, stock liquid enters fractionation extraction system from extraction section last step, washing composition enters fractionation extraction system from the washing section first step, mix with stock liquid at the last step of extraction section, enter extraction section together, extraction phase carries out multi-stage countercurrent mutually with washing and contacts.Flow out the extraction liquid being rich in eicosa-pentaenoic acid esters (EPA ester) and docosahexenoic acid ester (DHA ester) from the washing section first step, collect extraction liquid; Flow out the raffinate being rich in low unsaturated and polyunsaturated fatty acid ester from the extraction section first step, collect raffinate.
Embodiment 1
By the mixture (ester type fish oil) of fatty-acid ethyl ester, be dissolved in normal hexane, be made into the stock liquid that fatty-acid ethyl ester total concn is 40g/L, wherein, the massfraction about 5% of EPA-EE+DHA-EE.Be extraction agent with DMF, take normal hexane as washing composition, the stream of stock liquid, extraction agent, washing composition three carries out fractionation extraction than for 0.4:0.5:1.2 at 30 DEG C, collects extraction liquid and raffinate.By extraction liquid through normal hexane back extraction, vacuum concentration, obtain the mixture of EPA-EE+DHA-EE.Wherein, the purity of EPA-EE+DHA-EE is 91.1%, and yield is 94.6%.
Embodiment 2
Be dissolved in octane by the mixture (the micro-algae oil of ester type) of fatty acid methyl ester, preparation fatty acid methyl ester total concn is the stock liquid of 60g/L, the wherein content about 6% of EPA methyl esters+DHA methyl esters.Being extraction agent with dimethyl sulfoxide (DMSO), take octane as washing composition, and the stream of stock liquid, extraction agent, washing composition three, than being 0.2:0.4:2, carries out fractionation extraction at 35 DEG C, collects extraction liquid and raffinate.By extraction liquid through octane back extraction, vacuum concentration, obtain the mixture of EPA methyl esters+DHA methyl esters.Wherein, the purity of EPA methyl esters+DHA methyl esters is 94.1%, and yield is 86.5%.
Embodiment 3
The mixture (the micro-algae oil of ester type) of fatty acid ester is dissolved in sherwood oil, is mixed with the stock liquid that fatty acid methyl ester total concn is 80g/L, wherein, the content about 25% of EPA methyl esters+DHA methyl esters.With 1-butyl-3-Methylimidazole thiocyanate ion liquid for extraction agent, take sherwood oil as washing composition, the stream of stock liquid, extraction agent, washing composition three carries out fractionation extraction than for 0.4:0.6:2.5 at 25 DEG C, collects extraction liquid and raffinate.By extraction liquid through sherwood oil back extraction, vacuum concentration, obtain the mixture of EPA methyl esters+DHA methyl esters.Wherein, the purity of EPA methyl esters+DHA methyl esters is 96.8%, and yield is 83.2%.
Embodiment 4
The mixture (ester type fish oil) of fatty-acid ethyl ester is dissolved in normal hexane, is mixed with the stock liquid that fatty-acid ethyl ester total concn is 40g/L, wherein, the content about 30% of EPA-EE+DHA-EE.With 1-butyl-3-Methylimidazole dintrile amine salt ionic liquid for extraction agent, take normal hexane as washing composition, the stream of stock liquid, extraction agent, washing composition three, than being 0.2:0.4:1.8, carrying out fractionation extraction and collects extraction liquid and raffinate at 30 DEG C.By extraction liquid through normal hexane back extraction, vacuum concentration, obtain the mixture of EPA-EE+DHA-EE.Wherein, the purity of EPA-EE+DHA-EE is 94.8%, and yield is 87.4%.
Embodiment 5
The mixture (the micro-algae oil of ester type) of fatty acid ester is dissolved in normal hexane, is mixed with the stock liquid that fatty acid methyl ester total concn is 20g/L, wherein, the content about 50% of EPA methyl esters+DHA methyl esters.With N-butyl-pyridinium acetate ionic liquid for extraction agent, take normal hexane as washing composition, the stream of stock liquid, extraction agent, washing composition three, than being 0.5:0.5:3, carrying out fractionation extraction, collects extraction liquid and raffinate at 20 DEG C.By extraction liquid through normal hexane back extraction, vacuum concentration, obtain the mixture of EPA methyl esters+DHA methyl esters.Wherein, the purity of EPA methyl esters+DHA methyl esters is 93.5%, and yield is 89.1%.
Embodiment 6
The mixture (ester type fish oil) of fatty-acid ethyl ester is dissolved in normal hexane, is mixed with the stock liquid that fatty-acid ethyl ester total concn is 40g/L, wherein, the content about 80% of EPA-EE+DHA-EE.With 1-ethyl-3-methylimidazole three nitrile carbon ionic liquid for extraction agent, take normal hexane as washing composition, the stream of stock liquid, extraction agent, washing composition three, than being 0.8:0.6:2, carrying out fractionation extraction, collects extraction liquid and raffinate at 40 DEG C.By extraction liquid through normal hexane back extraction, vacuum concentration, obtain the mixture of EPA-EE+DHA-EE.Wherein, the purity of EPA-EE+DHA-EE is 96.2%, and yield is 89.2%.
Embodiment 7
The mixture (the micro-algae oil of ester type) of fatty acid methyl ester is dissolved in normal hexane, is mixed with the stock liquid that fatty acid methyl ester total concn is 150g/L, wherein, the content about 35% of EPA methyl esters+DHA methyl esters.With 1-butyl-3-methyl imidazolium tetrafluoroborate ionic liquid-N, dinethylformamide binary mixed solvent (in mixed solvent, the massfraction of 1-methyl-3-octylimidazole tetrafluoroborate ion liquid is 20%) is extraction agent, take normal hexane as washing composition, the stream of stock liquid, extraction agent, washing composition three is than being 0.5:0.4:1.9, at 30 DEG C, carry out fractionation extraction, collect extraction liquid and raffinate.By extraction liquid through normal hexane back extraction, vacuum concentration, obtain the mixture of EPA methyl esters+DHA methyl esters.Wherein, the purity of EPA methyl esters+DHA methyl esters is 96.0%, and yield is 91.8%.
Embodiment 8
The mixture (ester type fish oil) of fatty-acid ethyl ester is dissolved in normal heptane, is mixed with the stock liquid that fatty-acid ethyl ester total concn is 180g/L, wherein, the content about 50% of EPA-EE+DHA-EE.With tetraethyl-amine-dicyanamide ionic liquid-dimethyl sulfoxide (DMSO) binary mixed solvent (in mixed solvent, the massfraction of tetraethyl-amine-dicyanamide ionic liquid is for 50%) for extraction agent with normal heptane for washing composition, the stream of stock liquid, extraction agent, washing composition three is than being 0.4:0.4:1.3, at 30 DEG C, carry out fractionation extraction, collect extraction liquid and raffinate.By extraction liquid through normal heptane back extraction, vacuum concentration, obtain the mixture of EPA-EE+DHA-EE.Wherein, the purity of EPA-EE+DHA-EE is 91.9%, and yield is 83.1%.
Embodiment 9
The mixture (the micro-algae oil of ester type) of fatty acid methyl ester is dissolved in normal hexane, is mixed with the stock liquid that fatty acid methyl ester total concn is 100g/L, wherein, the content about 15% of EPA methyl esters+DHA methyl esters.With choline lauroleate ionic liquid-N, dinethylformamide binary mixed solvent (in mixed solvent, the massfraction of choline lauroleate ionic liquid is 70%) is extraction agent, take normal hexane as washing composition, the stream of stock liquid, extraction agent, washing composition three is than being 0.4:0.6:1, at 30 DEG C, carry out fractionation extraction, collect extraction liquid and raffinate.By extraction liquid through normal hexane back extraction, vacuum concentration, obtain the mixture of EPA methyl esters+DHA methyl esters.Wherein, the purity of EPA methyl esters+DHA methyl esters is 98.5%, and yield is 84.3%.
Claims (7)
1. the method for separation and purification eicosa-pentaenoic acid esters and docosahexenoic acid ester from ester type micro-algae oil or fish oil, is characterized in that, comprise the following steps:
(1) micro-for ester type algae oil or ester type fish oil are dissolved in non-polar solvent preparation raw material liquid, the binary mixed solvent formed with ionic liquid or ionic liquid-polar solvent is for extraction agent, with the solvent identical with material solution for washing composition, carry out fractionation extraction, collect extraction liquid;
Described ionic liquid is by positively charged ion M
+and anion N
-two portions are formed:
Described positively charged ion M
+for the one that there is single or multiple substituent choline cation, there is single or multiple substituting group glyoxaline cation, there is single or multiple substituent pyridine type positively charged ion, there is single or multiple substituting group quaternary ammonium cation and have in single or multiple substituting group benzimidazolium;
Anion N
-for the one that carbonatoms is in the fatty acid radical of 1-18, thiocyanate ion, dicyanamide root, three cyanogen methane roots, four cyanogen borates, halide-ions, tetrafluoroborate and phenol;
Described polar solvent to be carbon atom number be 1 ~ 4 monohydroxy-alcohol, carbon atom number be one in the polyvalent alcohol of 1 ~ 4;
The massfraction of described binary mixed solvent intermediate ion liquid is 5 ~ 70%;
(2) described extraction liquid is stripped through described non-polar solvent, strip liquor is obtained after vacuum concentration, washing also drying the mixture of eicosa-pentaenoic acid esters and docosahexenoic acid ester.
2. method according to claim 1, is characterized in that, described substituting group to be carbonatoms be 1 ~ 8 alkyl.
3. method according to claim 1, it is characterized in that, described non-polar solvent is the one in normal hexane, normal heptane, octane and sherwood oil.
4. method according to claim 1, it is characterized in that, the micro-algae oil of described ester type is methyl esters type, and in the micro-algae oil of ester type, the total mass mark of eicosa-pentaenoic acid esters and docosahexenoic acid ester is 5% ~ 50%; Described ester type fish oil is ethyl ester type, and in ester type fish oil, the total mass mark of eicosa-pentaenoic acid esters and docosahexenoic acid ester is 5% ~ 80%.
5. method according to claim 1, it is characterized in that, in described stock liquid, the total concn of fatty acid ester is 10 ~ 200g/L.
6. method according to claim 1, it is characterized in that, the temperature of described fractionation extraction is 20 ~ 40 DEG C.
7. method according to claim 1, is characterized in that, described stock liquid, heating up in a steamer than being 0.2 ~ 0.8:0.3 ~ 0.8:0.8 ~ 3 between extraction agent and washing composition three.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310319421.6A CN103396310B (en) | 2013-07-25 | 2013-07-25 | Method for separating and purifying eicosapentaenoic acid ester and docosahexenoic acid ester from micro-algal oil or fish oil |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310319421.6A CN103396310B (en) | 2013-07-25 | 2013-07-25 | Method for separating and purifying eicosapentaenoic acid ester and docosahexenoic acid ester from micro-algal oil or fish oil |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103396310A CN103396310A (en) | 2013-11-20 |
CN103396310B true CN103396310B (en) | 2015-02-25 |
Family
ID=49560095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310319421.6A Active CN103396310B (en) | 2013-07-25 | 2013-07-25 | Method for separating and purifying eicosapentaenoic acid ester and docosahexenoic acid ester from micro-algal oil or fish oil |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103396310B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104001540B (en) * | 2014-02-12 | 2016-04-06 | 南昌航空大学 | A kind of ionic-liquid catalyst and preparation method thereof |
CN105384635B (en) * | 2014-09-09 | 2018-03-09 | 浙江医药股份有限公司新昌制药厂 | A kind of method that the fatty-acid ethyl esters of Omega 3 are isolated and purified from fish oil |
CN105132189B (en) * | 2015-08-06 | 2018-07-24 | 天津大学 | A kind of fine separation method of C18 series and C20~C22 series fatty acid methyl esters |
CN105062694B (en) * | 2015-08-06 | 2018-07-24 | 天津大学 | A kind of method that C18 series fatty acids and C20~C22 series fatty acids finely detach |
CN107459455B (en) * | 2016-06-02 | 2020-08-11 | 中国石化扬子石油化工有限公司 | Method for extracting methyl stearate from benzoyl methane stearate residual liquid |
CN111116353A (en) * | 2020-01-02 | 2020-05-08 | 广西小藻农业科技有限公司 | Method for purifying EPA in microalgae oil |
CN115466180A (en) * | 2022-09-13 | 2022-12-13 | 江苏海莱康生物科技有限公司 | Method for purifying eicosapentaenoic acid ethyl ester |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1055079C (en) * | 1996-08-23 | 2000-08-02 | 中国科学院化学研究所 | Extraction method of unsaturated fatty acid from fish oil |
CN1084380C (en) * | 1999-08-30 | 2002-05-08 | 朱惠祥 | Process for producing refined fish oil with high polyenoic acid ethyl ester content from crude fish oil |
-
2013
- 2013-07-25 CN CN201310319421.6A patent/CN103396310B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN103396310A (en) | 2013-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103396310B (en) | Method for separating and purifying eicosapentaenoic acid ester and docosahexenoic acid ester from micro-algal oil or fish oil | |
CN103396303B (en) | Method for separating and purifying eicosapentaenoic acid and docosahexaenoic acid from micro-algal oil or fish oil | |
CN104529772B (en) | A kind of simulated moving bed chromatography prepares high-purity EPA ester and the method for DHA ester monomer | |
CN102001947A (en) | Method for preparing honeysuckle chlorogenic acid | |
CN112592268B (en) | Method for separating EPA (eicosapentaenoic acid) in fish oil by using continuous chromatographic system | |
JP2013542927A5 (en) | ||
CN105272844B (en) | Method for purifying high-purity fish oil EPA(eicosapentaenoic acid) ethyl ester and DHA(docosahexaenoic acid) ethyl ester | |
JP2020090680A (en) | Chromatographic process for the production of highly purified polyunsaturated fatty acids | |
CN101278743A (en) | Silkworm pupa oil and extracting method and applications | |
CN107216252A (en) | A kind of preparation method of high content Omega-3 fatty-acid ethyl esters | |
US8802880B1 (en) | Chromatographic process for the production of highly purified polyunsaturated fatty acids | |
CN103254225A (en) | Method for extracting and separating and purifying phosphatidylcholine by use of ionic liquid | |
KR20160096110A (en) | Method for chromatographic purification of a fatty acid | |
CN106590939A (en) | Method for purification preparation of high content linoleic acid by using vegetable oil as raw material | |
CN102070647B (en) | Method for separating ginkgolide B from ginkgolide mixture | |
CN103288870B (en) | A kind of preparation method of injection stage lecithin in high purity | |
CN104311613A (en) | Method for extracting oleuropein from olive leaves | |
CN108164415B (en) | Method for completely separating EPA and DHA from fish oil | |
CN103865642B (en) | A kind of preparation method of non-solvent high purity DHA algal oil | |
CN102381974A (en) | Method for separating and preparing caffeic tannic acid from honeysuckle by utilizing high speed countercurrent chromatography | |
CN117209376A (en) | Method for completely separating oleic acid and linoleic acid | |
CN107162910B (en) | Method for preparing high-purity EPA-EE from fish oil | |
CN116375784A (en) | Method for separating hyodeoxycholic acid and chenodeoxycholic acid | |
US9428711B2 (en) | Chromatographic process for the production of highly purified polyunsaturated fatty acids | |
CN103086873B (en) | High speed adverse current chromatogram is separated preparation high purity DHA method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |